PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Cancer Cell. Author manuscript; available in PMC 2013 January 17.
Published in final edited form as:
PMCID: PMC3266838
NIHMSID: NIHMS348132

Mdm2’s Dilemma: To Degrade or To Translate p53?

Abstract

In this issue of Cancer Cell, Gajjar et al. provide insight into how Mdm2 can both inhibit and enhance p53 activity. In the basal setting, Mdm2 binds p53 and promotes p53 degradation. Under stress conditions, ATM-dependent phosphorylation of Mdm2 results in its recruitment to p53 mRNA, thereby stimulating p53 translation.

The p53 tumor suppressor is a transcription factor that is induced in response to a variety of stress signals (Kruse and Gu, 2009). Under normal conditions, the p53 protein is kept at low levels in cells by ubiquitination-dependent proteosomal degradation mediated by its negative regulator, the E3 ubiquitin ligase Mdm2 (Figure 1A). Mdm2 is also a p53 transcriptional target, and thus participates in a negative feedback loop with p53. Stress-mediated upregulation of Mdm2 has been considered a means by which p53 is able to regulate the duration and amplitude of its cellular effects.

Figure 1
Mdm2 Acts as a Positive or Negative Regulator of p53 Activity in Response to Different Stresses

In response to activation of specific oncogenic pathways, the ARF tumor suppressor is upregulated. ARF, in turn, interferes with Mdm2-dependent inhibition of p53 (Manfredi, 2010) (Figure 1B). In contrast, stimulation of the p53 pathway by genotoxic stress involves the DNA damage-activated kinase ATM, which has been shown to directly phosphorylate both p53 and Mdm2 (Kruse and Gu, 2009; Manfredi, 2010) (Figure 1C). The significance of ATM-dependent phosphorylation of Mdm2 was confirmed by the observation that phosphorylation of serine 395 on Mdm2 led to impaired p53 degradation (Maya et al., 2001). Biochemical studies have indicated that this is likely due to altered oligomerization, thereby attenuating the processivity of the E3 ligase activity of Mdm2 (Cheng et al., 2009). DNA damage has also been shown to induce the relocalization of Mdm2 to the nucleolus (Bernardi et al., 2004). It has been proposed that a nucleotide-binding motif within the Mdm2 E3 ligase RING domain facilitates nucleolar localization of Mdm2 (Poyurovsky et al., 2003). Candeias et al. then made the surprising observation that the p53 mRNA itself was able to interact directly with the RING domain of Mdm2. This interaction impaired the E3 ligase activity of Mdm2 and promoted p53 mRNA translation (Candeias et al., 2008). It was unclear, however, under what biological settings such an interaction would have relevance.

In this issue of Cancer Cell, Gajjar et al. provide important insight by demonstrating that the DNA damage- and ATM-dependent phosphorylation of Mdm2 on serine 395 promotes the interaction of Mdm2 with p53 mRNA. This, in turn, is needed for p53 stabilization and apoptotic activity (Gajjar et al., 2012) (Figure 1D). By means of RNAi and overexpression experiments, these authors show that both ATM and Mdm2 are required to achieve full p53 apoptotic activity after DNA damage. Use of an Mdm2 isoform that does not bind to the p53 protein shows that a protein-protein interaction between Mdm2 and p53 is remarkably dispensable for this. It was further demonstrated that the interaction between p53 mRNA and the Mdm2 RING domain is necessary for p53-dependent apoptosis after genotoxic stress. Studies using a mutated p53 mRNA that no longer binds Mdm2 confirmed findings with a mutant Mdm2 protein that has a reduced affinity for the mRNA. These intriguing results support the notion that ATM-mediated phosphorylation of Mdm2 at serine 395 promotes allosteric changes in the RING domain, which in turn facilitate p53 mRNA binding. Finally, Gajjar et al. show that after DNA damage, the interaction between Mdm2 and p53 mRNA impairs Mdm2-dependent ubiquitination of p53. Thus, it is argued that the p53 mRNA-MDM2 interaction not only increases p53 translation, but also inhibits p53 protein degradation as well.

In sum, this study demonstrates that Mdm2 can act as a positive regulator of p53 activity after genotoxic stress. It further provides an additional novel explanation for why Mdm2 is transcriptionally upregulated by p53 after DNA damage.

The finding that p53 mRNA relocalizes with Mdm2 in the nucleolus after DNA damage is especially interesting since the nucleolus is generally thought of as the site of ribosomal RNA transcription. However, several studies support the idea that it might also be involved in the processing or nuclear export of specific messenger RNAs (Pederson, 2011). Nevertheless, little is known about the relationship between mRNA and the nucleolus. The present study rekindles the idea that the nucleolus and mRNA processing are functionally connected.

While these nucleolar events are intriguing, the key outcome is an enhancement of p53 protein synthesis, a process that occurs in the cytoplasm. With this in mind, a molecular explanation is still needed for how p53 mRNA is then relocated from the nucleolus to the cytoplasm. In their previous study, Fahraeus and collaborators showed that Mdm2 is associated with polysomes in the cytoplasm, raising the intriguing possibility that Mdm2 is actually exported to the cytoplasm along with p53 mRNA and that Mdm2 may enhance p53 translation once there (Candeias et al., 2008). Mdm2 is known to interact with several ribosomal proteins (Zhang and Lu, 2009). These interactions may indeed be at play in this process. The molecular mechanism by which the transient Mdm2-dependent nucleolar targeting of p53 mRNA enhances its translation also remains to be explored.

In summary, the significance of the study lies not only in its elucidation of a new role for p53-mediated induction of Mdm2 after DNA damage, it begins to provide a molecular explanation for how Mdm2 may act either as an oncogene or a tumor suppressor, depending upon the particular context (Manfredi, 2010). This latter notion has important implications for the prognosis and treatment of tumors with aberrant Mdm2 expression.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • Bernardi R, Scaglioni PP, Bergmann S, Horn HF, Vousden KH, Pandolfi PP. PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat Cell Biol. 2004;6:665–672. [PubMed]
  • Candeias MM, Malbert-Colas L, Powell DJ, Daskalogianni C, Maslon MM, Naski N, Bourougaa K, Calvo F, Fahraeus R. p53 mRNA controls p53 activity by managing Mdm2 functions. Nat Cell Biol. 2008;10:1098–1105. [PubMed]
  • Cheng Q, Chen L, Li Z, Lane WS, Chen J. ATM activates p53 by regulating MDM2 oligomerization and E3 processivity. Embo J. 2009;28:3857–3867. [PubMed]
  • Gajjar M, Candeias MM, Malbert-Colas L, Mazars A, Fujita J, Olivares-Illana V, Fahraeus R. The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage. Cancer Cell. 2012 in press. [PubMed]
  • Kruse JP, Gu W. Modes of p53 regulation. Cell. 2009;137:609–622. [PMC free article] [PubMed]
  • Manfredi JJ. The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor. Genes Dev. 2010;24:1580–1589. [PubMed]
  • Maya R, Balass M, Kim ST, Shkedy D, Leal JF, Shifman O, Moas M, Buschmann T, Ronai Z, Shiloh Y, et al. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 2001;15:1067–1077. [PubMed]
  • Pederson T. The nucleolus. Cold Spring Harbor perspectives in biology. 2011;3 [PMC free article] [PubMed]
  • Poyurovsky MV, Jacq X, Ma C, Karni-Schmidt O, Parker PJ, Chalfie M, Manley JL, Prives C. Nucleotide binding by the Mdm2 RING domain facilitates Arf-independent Mdm2 nucleolar localization. Mol Cell. 2003;12:875–887. [PubMed]
  • Zhang Y, Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell. 2009;16:369–377. [PubMed]